Latest Posts › Food and Drug Administration (FDA)

Share:

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

COVID-19 Weekly Newsletter: Additional Booster Shots Recommended as FDA Prepares to Evaluate Vaccines for Younger Children

Booster Shot Endorsements - Last week, the U.S. Food and Drug Administration (FDA) advisory committee endorsed one of the mRNA COVID-19 vaccines and the single-dose vaccine to be used as a booster shot. This week, FDA...more

COVID-19 Weekly Newsletter: FDA Considers COVID-19 Pill, Travel Restrictions To Be Lifted

A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more

COVID-19 Weekly Newsletter: A Pill To Treat COVID-19?

A promising new COVID-19 treatment grabbed headlines this week, along with new updates on one mRNA vaccine manufacturer’s path to potentially seeking Food and Drug Administration (FDA) approval on vaccines for children...more

COVID-19 Weekly Newsletter: Domestic and International Vaccine News

Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more

COVID-19 Weekly Newsletter: Updates on Vaccines for Children and Potential Authorization for Booster Shots

Amid continued spread of the Delta variant and sobering new studies about the toll COVID-19 has exacted on medical staff, vaccine manufacturers and public health leaders continue to seek solutions — including efforts to...more

COVID-19 Weekly Newsletter: Biden Announces New Pandemic Plan

On September 9, President Biden announced a new six-pronged plan to address COVID-19, which includes bold steps aimed at increasing vaccination rates. Biden’s Path Out of the Pandemic Plan - On Thursday, President...more

COVID-19 Weekly Newsletter: EU Restricts Travel, U.S. Boosts Vaccine Supply Chain

The European Union removed the U.S. from its safe travel list earlier this week, as the Biden administration took measures to bolster the vaccine supply chain to meet the anticipated rise in demand. Children Account for...more

COVID-19 Weekly Newsletter: Full FDA Approval

The COVID-19 vaccine approval process reached a major milestone, but the fourth U.S. wave of the COVID-19 virus has prompted some sobering projections about the future of the pandemic. COVID-19 Vaccine Receives Full FDA...more

COVID-19 Weekly Newsletter: Booster Shots Continue To Gain Steam

Recent announcements on the prospect of booster shots for all vaccinated Americans, a vaccine mandate for staff at federally funded nursing homes and an encouraging uptick in vaccinations marked an eventful week in the...more

COVID-19 Weekly Newsletter: Response to Delta Variant Intensifies

FDA Authorizes Booster Shots for Immunocompromised - The United States Food and Drug Administration updated its emergency use authorizations for two currently authorized COVID-19 vaccines on Thursday, sanctioning third...more

COVID-19 Weekly Newsletter: Formidable Delta Variant Prompts Vaccine Mandates

Vaccinated Individuals Infected With Delta Variant May Carry as Much Virus as Unvaccinated - The U.S. Centers for Disease Control and Prevention (CDC) updated their mask guidance on July 27, 2021, recommending that...more

COVID-19 Weekly Newsletter: CDC Updates Guidance

New federal guidance on masking and testing highlighted an eventful week in the COVID-19 response, as government authorities work to respond to the rising transmission of the Delta variant. CDC Updates Masking and...more

COVID-19 Weekly Newsletter: Cases on the Rise in All 50 States

Cases on the Rise in All 50 States This week marks the first time in months that all 50 states are seeing a rise in cases, with more than 30 states seeing at least a 50% increase over the previous week. The U.S. Centers for...more

COVID-19 Weekly Newsletter: Variants and Vaccine Hesitancy

As the delta variant becomes more prominent in the U.S., public health authorities look for ways to address vaccine hesitancy, and the scientific community seeks to better understand viruses — as our list of identified...more

COVID-19 Weekly Newsletter: Delta Variant a Threat to the Unvaccinated

Delta Variant Accounts for 20% of Samples Tested - The delta variant, first identified in India a few months ago and now present in 90-plus countries, is more transmissible and deadly than previous variants that have...more

Long-Awaited 21st Century Cures Act 2.0 Draft Released

Following months of anticipation by stakeholders including patient organizations, research institutions and medical product developers, Representatives Fred Upton (R-MI) and Diana DeGette (D-DO) released a 21st Century Cures...more

COVID-19 Weekly Newsletter: U.S. Vaccination Effort Goes International

While actively launching new initiatives and incentives to boost the vaccination rate within its own population, the U.S. government this week announced its plans to share portions of its vaccine stockpile...more

COVID-19 Weekly Newsletter: WHO Sets Global Vaccine Goals for 2021

This week, the World Health Organization (WHO) laid out its goals for boosting vaccination rates worldwide and also asked world leaders to provide additional funding for global vaccination efforts. In other COVID-19...more

COVID-19 Weekly Newsletter: 60% of American Adults Have Received One Vaccine Dose

With vaccination rates climbing, this week marked an encouraging turn on the path to a more “normal” summer and avoiding a fall resurgence. FDA Opposes Antibody Testing To Evaluate Immunity Response - On Wednesday,...more

COVID-19 Weekly Newsletter: Positive Signs on Path to Normalcy, Teenagers Approved for Vaccines

The Centers for Disease Control and Prevention (CDC) made waves this week with its announcement that fully vaccinated individuals can begin congregating indoors. Coupled with the announcement that teenagers are eligible for...more

COVID-19 Weekly Newsletter: Guidance and Developments as Global Vaccination Continues

This week, the CDC announced updated guidance regarding outdoor gatherings, and the Department of Labor is advancing new workplace safety standards. Meanwhile, dwindling U.S. vaccination rates and global vaccine access are...more

COVID-19 Weekly Newsletter: Preventing the Next Pandemic

A recent study of one of the two mRNA-based vaccines revealed positive news on how long the vaccine will effectively prevent against COVID-19 infection. The pandemic has also revealed societal weaknesses that, if addressed,...more

COVID-19 Weekly Newsletter: 116 Million Vaccines

It was a largely encouraging week in the U.S. COVID-19 response, where the vaccination rollout continues to outpace initial goals. Elsewhere, the World Health Organization (WHO) weighed in on the idea of requiring...more

COVID-19 Weekly Newsletter: Leaders Ponder Return to Normalcy

With significant headway in the vaccine distribution and certain states already lifting COVID-19 restrictions, U.S. leaders are beginning to contemplate when we might return to some semblance of normalcy. Two Million...more

36 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide